Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.75    1.20 (18.32%)
Bid:
7.50
Ask:
8.00
Spread: 0.50 (6.667%)
Market Cap: £9.26m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Trading Update

4 Mar 2021 15:24

Marechale Capital Plc - Trading Update

Marechale Capital Plc - Trading Update

PR Newswire

London, March 4

04 March 2021

Marechale Capital plc

(“Marechale” or the “Company”)

Trading Update

Marechale Capital Plc (AIM: MAC) provides an update on its current trading.

Further to the announcement of 26 January 2021, Marechale recently completed a strategic fundraising to put the Company in a better position to take advantage of opportunities that are presented to Marechale in connection with its work for corporate clients whereby Marechale takes shares, founder shares or long term warrants in lieu of or in addition to cash fees. The Company sees significant potential for growth within the technology, alternative and renewable energy and leisure and hospitality sectors as the economy recovers from the current pandemic and the Directors consider that a stronger balance sheet will allow it greater scope to capitalise on and participate in client financing opportunities on advantageous terms.

Recent transactions concluded by the Company include providing strategic advice to a high growth energy business, which is planning a realisation event in the short term, whereby the Company was able to receive a greater proportion of shares and warrants as part of its advisory fees. In addition, Marechale is now better positioned to invest in and support its corporate clients alongside its investor relationships which it has recently done with a growing global technology group which is on the cusp of its first commercial contract. In this transaction, the Company received further shares in a new equity round, at a premium valuation to previous rounds, together with increasing its warrant position. Finally, the Company completed a short-term, high yielding loan note funding round through its investor contacts, in which it was also able to participate and receive warrants, for a UK hospitality brand with the potential for high growth. The board believes these investments and other maturing warrants and equity and founder equity investments in the Marechale corporate finance portfolio have the potential to generate material value to shareholders.

Marechale is an established corporate finance firm providing strategic, M&A and advisory services helping to provide finance for earlier stage and growth capital companies from its family office, private investor and private equity relationships where it often co invests. The majority of the Company’s recent share placing funding has been invested in, or committed to, a number of these completed and ongoing transactions, taking the form of equity at attractive valuations and short-term, high yielding loans with warrants attached.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

For further information please contact:

Marechale Capital plc Mark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLP (Nomad) Jo Turner / Sandy Jamieson / Mark RogersTel: +44 (0)20 7213 0880
Novum Securities Limited (Broker) Colin RowburyTel: +44 (0)20 7399 9427
Date   Source Headline
8th Jun 20267:00 amPRNFCA Approves Stanford Capital Partners Change in Control
3rd Jun 20267:00 amPRNPosting of Circular and Notice of General Meeting
10th Apr 20261:00 pmPRNWeardale Lithium Receives £700k Grant
19th Jan 202612:15 pmPRNHalf-year Report
14th Oct 20254:00 pmPRNResult of AGM
14th Oct 20257:00 amPRNSubscription, Directors' Dealings, Related Party Transaction and Issue of Equity
16th Sep 20259:30 amPRNNotice of AGM
22nd Aug 20257:00 amPRNFinal Results
13th May 20257:00 amPRNIssue of Options to PDMR
19th Mar 20257:00 amPRNMarechale Advises on the Sale of Randalls
5th Feb 20251:30 pmPRNWeardale Lithium Planning Permission Application Update
29th Jan 202511:37 amPRNShare Price Movement
19th Dec 20244:30 pmPRNHalf-year Report
15th Oct 20242:30 pmPRNResult of AGM
20th Sep 20247:00 amPRNNotice of AGM
20th Aug 20247:00 amPRNFinal Results
6th Aug 20247:00 amPRNAppointment of Director
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.